Proprio, based in Seattle, makes Paradigm, a surgical navigation platform that uses light field imaging, computer vision and machine learning to build a continuous, radiation-free 3D view of the patient during spine surgery. It raised a $43 million Series B in 2023.
At a glance
| Price from | Custom |
| Best for | Spine surgeons who want navigation without extra imaging |
From Proprio's own website.
What stands out
- Four FDA clearances
- Radiation-free 3D view
Worth knowing
- Spine surgery focus
- Smaller funding than peers
How it ranks
Proprio is ranked 10th of 10 in Best Medical Device Startups Using AI (Lister Score 85.3).
#10 in Best Medical Device Startups Using AI · Lister Score 85.3
Proprio received its fourth FDA clearance for Paradigm, for the Picasso registration feature, in January 2026..
| Rank | Best Medical Device Startups Using AI | Score |
|---|---|---|
| 1 | Aidoc | 96.9 |
| 2 | Exo | 95.6 |
| 3 | Eko Health | 94.3 |
| 4 | Viz.ai | 93.1 |
| 5 | Cleerly | 91.8 |
| 6 | Prenuvo | 90.5 |
| 7 | Ultromics | 89.2 |
| 8 | Qure.ai | 87.9 |
| 9 | Anumana | 86.6 |
| 10 | Proprio | 85.3 |
Frequently asked questions
How does Proprio rank on Lister?
Proprio is ranked 10th of 10 in Best Medical Device Startups Using AI (Lister Score 85.3).
Appears in
Add this badge to your site
If you work at Proprio, paste this code into your website to show where it ranks on Lister. The badge links to the ranking and updates within a day when the rank changes.